Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:34 pm Sale |
2025-02-27 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 2,494,110 9.990% |
-1,600,448 (-39.09%) |
Filing History |
| 2025-03-03 7:04 pm Purchase |
2025-02-27 | 13D | BiomX Inc. PHGE |
Flynn James E | 15,558,445 9.990% |
0 (+0.00%) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 4,094,558 19.990% |
3,161,500 (+338.83%) |
Filing History |
| 2024-11-13 5:30 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
Nantahala Capital Management, LLC | 1,794,141 9.990% |
1,794,141 (New Position) |
Filing History |
| 2024-11-13 5:14 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
AMR Action Fund L.P. | 876,888 4.900% |
876,888 (New Position) |
Filing History |
| 2024-11-04 4:05 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
Burbank John Howard III | 510,205 2.900% |
510,205 (New Position) |
Filing History |
| 2024-10-28 4:01 pm Purchase |
2024-09-30 | 13G | BIOMX INC UNIT 1 COM & 1 WT EX PHGEU |
Rodney Hodges | 560,267 3.100% |
560,267 (New Position) |
Filing History |
| 2024-07-17 8:40 pm Purchase |
2024-07-15 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 17,877,653 9.990% |
5,299,832 (+42.14%) |
Filing History |
| 2024-07-11 6:47 pm Purchase |
2024-07-09 | 13D | BiomX Inc. PHGE |
Flynn James E | 15,558,445 9.990% |
14,947,435 (+2446.35%) |
Filing History |
| 2024-05-30 7:26 pm Unchanged |
2024-05-30 | 13D | BiomX Inc. PHGE |
Flynn James E | 611,010 8.750% |
0 (Unchanged) |
Filing History |
| 2024-03-26 4:30 pm Purchase |
2024-03-26 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 933,058 15.600% |
477,827 (+104.96%) |
Filing History |
| 2024-03-25 3:35 pm Purchase |
2024-03-15 | 13G | BiomX Inc. PHGE |
AMR Action Fund L.P. | 305,487 5.500% |
305,487 (New Position) |
Filing History |
| 2024-03-22 5:44 pm Purchase |
2024-03-15 | 13D | BiomX Inc. PHGE |
Flynn James E | 611,010 11.060% |
611,010 (New Position) |
Filing History |
| 2024-03-19 9:11 pm Purchase |
2024-03-15 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 12,577,821 19.900% |
7,976,013 (+173.32%) |
Filing History |
| 2024-03-08 4:30 pm Purchase |
2024-03-06 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 4,601,808 9.900% |
48,319 (+1.06%) |
Filing History |
| 2024-02-13 1:09 pm Sale |
2023-12-31 | 13G | BiomX Inc. PHGE |
MMCAP International Inc. SPC | 152,799 3.220% |
-69,489 (-31.26%) |
Filing History |
| 2024-02-02 5:07 pm Sale |
2023-12-31 | 13G | BiomX Inc. PHGE |
JOHNSON & JOHNSON JNJ |
211,340 4.600% |
-2,000 (-0.94%) |
Filing History |
| 2024-01-30 4:05 pm Purchase |
2024-01-30 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 455,232 9.900% |
180,133 (+65.48%) |
Filing History |
| 2023-09-29 09:20 am Purchase |
2023-05-04 | 13G | BiomX Inc. PHGE |
Rodney Hodges | 283,971 6.200% |
283,971 (New Position) |
Filing History |
| 2023-06-23 4:50 pm Purchase |
2023-05-04 | 13G | BiomX Inc. PHGE |
Burbank John Howard III | 459,819 9.990% |
459,819 (New Position) |
Filing History |